Related Experiment Video
Updated: Jul 11, 2025
02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
667
Malignant priapism: case report and update on management protocols.
Seyed Sajjad Tabei1, Wesley Baas1, Anthony Brooks2
1Division of Urology, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Translational Andrology and Urology
|November 16, 2023
Summary
Malignant priapism, a rare condition, requires individualized palliative care. This study suggests penectomy as a last resort for symptom relief in advanced genitourinary cancers.
Area of Science:
- Urology
- Oncology
- Medical Research
Background:
- Malignant priapism is a rare condition (approx. 500 cases) caused by neoplasm invasion or metastasis.
- Established priapism guidelines do not cover malignant cases.
- This study presents three cases of malignant priapism linked to advanced genitourinary cancers.
Observation:
- Patients presented with sub-acute penile pain.
- All patients underwent palliative penectomy.
- Penectomy provided sustained symptom relief.
Findings:
- Malignant priapism is associated with poor prognosis, necessitating palliative care.
- Conventional treatments like shunting may not be effective.
- Penectomy is a viable last resort for symptom management.
Implications:
- Individualized treatment plans are crucial for malignant priapism.
- Current priapism management guidelines require revision.
- Emphasis on palliative care is essential for these patients.
More Related Videos
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
162
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
162
01:14Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
01:20Disorders of the Male Reproductive System
426
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
426
01:27Peripheral Artery Disease III: Interprofessional Care
10
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
10
01:23Peripheral Artery Disease V: Postoperative Nursing Management
11
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
11
01:26Peripheral Artery Disease IV: Nursing Management
11
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
11